| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.0029 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.00091 | 1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.00063 | 1 |